BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19717508)

  • 1. Continue or withhold oral anticoagulation in high-risk patients undergoing pacemaker or ICD implantation.
    Daubert JC; Mabo P
    Eur Heart J; 2009 Aug; 30(15):1828a-1828c. PubMed ID: 19717508
    [No Abstract]   [Full Text] [Related]  

  • 2. Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial.
    Tolosana JM; Berne P; Mont L; Heras M; Berruezo A; Monteagudo J; Tamborero D; Benito B; Brugada J
    Eur Heart J; 2009 Aug; 30(15):1880-4. PubMed ID: 19487235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide.
    Jamula E; Douketis JD; Schulman S
    J Thromb Haemost; 2008 Oct; 6(10):1615-21. PubMed ID: 18638011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Continued oral anticoagulation during cardiac pacing: the BRUISE CONTROL study].
    Proietti R; Birnie DH; Healey JS; Verma A; Essebag V
    G Ital Cardiol (Rome); 2013 Nov; 14(11):724-5. PubMed ID: 24326634
    [No Abstract]   [Full Text] [Related]  

  • 5. Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy.
    Giudici MC; Paul DL; Bontu P; Barold SS
    Pacing Clin Electrophysiol; 2004 Mar; 27(3):358-60. PubMed ID: 15009863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation.
    Michaud GF; Pelosi F; Noble MD; Knight BP; Morady F; Strickberger SA
    J Am Coll Cardiol; 2000 Jun; 35(7):1915-8. PubMed ID: 10841243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: a randomized clinical trial.
    Cheng A; Nazarian S; Brinker JA; Tompkins C; Spragg DD; Leng CT; Halperin H; Tandri H; Sinha SK; Marine JE; Calkins H; Tomaselli GF; Berger RD; Henrikson CA
    Heart Rhythm; 2011 Apr; 8(4):536-40. PubMed ID: 21147261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing periprocedural anticoagulation therapy in patients undergoing device implantation: survey in Germany, Austria and Switzerland.
    Blaschke F; Lacour P; Wutzler A; Huemer M; Parwani AS; Attanasio P; Pieske B; Boldt L-; Haverkamp W
    Acta Cardiol; 2016; 71(5):549-556. PubMed ID: 27695012
    [No Abstract]   [Full Text] [Related]  

  • 9. Dual antiplatelet therapy and heparin "bridging" significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation.
    Tompkins C; Cheng A; Dalal D; Brinker JA; Leng CT; Marine JE; Nazarian S; Spragg DD; Sinha S; Halperin H; Tomaselli GF; Berger RD; Calkins H; Henrikson CA
    J Am Coll Cardiol; 2010 May; 55(21):2376-82. PubMed ID: 20488310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative anticoagulation for patients with mechanic heart valve(s) undertaking pacemaker implantation.
    Cheng M; Hua W; Chen K; Pu J; Ren X; Zhao X; Liu Z; Wang F; Chen X; Zhang S
    Europace; 2009 Sep; 11(9):1183-7. PubMed ID: 19666639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The BRUISE CONTROL study].
    Landolina ME; Savastano S; Piacenti M
    G Ital Cardiol (Rome); 2013 Nov; 14(11):719-23. PubMed ID: 24326633
    [No Abstract]   [Full Text] [Related]  

  • 12. No increased bleeding events with continuation of oral anticoagulation therapy for patients undergoing cardiac device procedure.
    Li HK; Chen FC; Rea RF; Asirvatham SJ; Powell BD; Friedman PA; Shen WK; Brady PA; Bradley DJ; Lee HC; Hodge DO; Slusser JP; Hayes DL; Cha YM
    Pacing Clin Electrophysiol; 2011 Jul; 34(7):868-74. PubMed ID: 21410724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of continuous oral anticoagulants versus heparin bridging in patients undergoing CIED surgery: reappraisal after the BRUISE study.
    Sant'anna RT; Leiria TL; Nascimento T; Sant'anna JR; Kalil RA; Lima GG; Verma A; Healey JS; Birnie DH; Essebag V
    Pacing Clin Electrophysiol; 2015 Apr; 38(4):417-23. PubMed ID: 25546244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative management of anticoagulation during device implantation-the UK perspective.
    de Bono J; Nazir S; Ruparelia N; Bashir Y; Betts T; Rajappan K
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):389-93. PubMed ID: 20132500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding risk of submuscular ICD implantation with continued oral anticoagulation versus heparin bridging therapy.
    Pecha S; Ayikli A; Wilke I; Hakmi S; Yildirim Y; Gosau N; Reichenspurner H; Willems S; Aydin MA
    Heart Vessels; 2018 Apr; 33(4):441-446. PubMed ID: 29030709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
    Ahmed I; Gertner E; Nelson WB; House CM; Dahiya R; Anderson CP; Benditt DG; Zhu DW
    Heart Rhythm; 2010 Jun; 7(6):745-9. PubMed ID: 20176137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of anticoagulation around pacemaker and defibrillator surgery.
    Birnie DH; Healey JS; Essebag V
    Circulation; 2014 May; 129(20):2062-5. PubMed ID: 24842933
    [No Abstract]   [Full Text] [Related]  

  • 18. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy.
    Wiegand UK; LeJeune D; Boguschewski F; Bonnemeier H; Eberhardt F; Schunkert H; Bode F
    Chest; 2004 Oct; 126(4):1177-86. PubMed ID: 15486380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oral anticoagulation doesn't increase hemorrhagic risk in patients undergoing a cardiac pacemaker or defibrillator implantation].
    Amara W; Ben Youssef I; Bonny A; Faron M; Monsel F; Sergent J
    Ann Cardiol Angeiol (Paris); 2010 Nov; 59(5):255-9. PubMed ID: 20883977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACP Journal Club. Warfarin continuation was better than heparin bridging during pacemaker or ICD surgery.
    Deloughery T
    Ann Intern Med; 2013 Aug; 159(4):JC7. PubMed ID: 24026283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.